A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung Cancer
Eligible lung cancer patients: Undergo pre-treatment 4D-CT study for treatment planning External Beam Radiation: standard fractionation (2Gy per day) or stereotactic body radiation therapy Evaluation: Repeat 4D-CT study at 3 months and 6 months post-treatment Primary objectives: To assess pre-treatment global and focal lung strain and correlate with changes post-treatment
Checked against the public recordLast updated Jun 22, 2021 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Louisville
- Interventions being studied
- Radiation: 4D-CT pre-treatment scan
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. Age \>/= 18 years 2. ECOG performance status 0-1 3. Pathologic or clinical diagnosis of lung malignancy 4. Patients must have a reproducible tidal volume sufficient for 4D-CT imaging 5. Negative serum pregnancy test within 2 weeks prior to registration for women of childbearing potential. 6. Women of childbearing potential and male participants who are sexually active must agree to use a medically effective means of birth control 7. Patients must provide study specific informed consent prior to study entry. Exclusion Criteria: 1. Patients with severe pulmonary dysfunction with non-reproducible tidal volumes sufficient for 4D-CT imaging. 2. Pregnant women or lactating women
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- James Graham Brown Cancer CenterLouisville, Kentucky
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 22, 2021. Always confirm current availability with the study team.